The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Chari Ravi S. since year 2005.
The trader's CIK number is 1632795.
At the time of this reporting, Chari Ravi S. is the SVP-Clinical Excellence of Hca Healthcare, Inc. .
(stock ticker symbol HCA).
See this page for all insider trading activities at Hca Healthcare, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-02-05||HCA||Hca Healthcare, Inc.||Option Ex||500||.00||0|
|2018-01-31||HCA||Hca Healthcare, Inc.||Option Ex||14,850||55.92||830,456|
|2018-02-01||HCA||Hca Healthcare, Inc.||Sale||10,568||102.29||1,081,000|
|2018-02-02||HCA||Hca Healthcare, Inc.||Sale||5,702||102.01||581,655|
|2017-03-27||HCA||Hca Healthcare, Inc.||Option Ex||31,956||16.54||528,392|
|2017-03-27||HCA||Hca Healthcare, Inc.||Sale||31,956||90.00||2,876,040|
|2017-02-05||HCA||Hca Healthcare, Inc.||Option Ex||500||.00||0|
|2017-02-06||HCA||Hca Healthcare, Inc.||Option Ex||564||.00||0|
|2017-02-01||HCA||Hca Healthcare, Inc.||Sale||15,901||82.00||1,303,882|
|2017-01-17||HCA||Hca Healthcare, Inc.||Option Ex||42,500||44.27||1,881,262|
|2016-02-08||HCA||Hca Healthcare, Inc.||Option Ex||614||.00||0|
|2016-02-05||HCA||Hca Healthcare, Inc.||Option Ex||500||.00||0|
|2016-02-06||HCA||Hca Healthcare, Inc.||Option Ex||562||.00||0|
|2015-08-06||HCA||Hca Healthcare, Inc.||Sale||11,166||90.78||1,013,649|
|2015-08-06||HCA||Hca Healthcare, Inc.||Option Ex||11,166||9.69||108,165|
|2015-02-06||HCA||Hca Healthcare, Inc.||Option Ex||562||.00||0|
|2015-02-08||HCA||Hca Healthcare, Inc.||Option Ex||612||.00||0|
|2015-02-05||HCA||Hca Healthcare, Inc.||Option Ex||500||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chari Ravi S. (SVP-Clinical Excellence of Hca Healthcare, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.